Neuropeptides and neuronal survival: Neuroprotective strategy for Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 814, Issue , 1997, Pages 161-166

  Gozes, I ^a   Bardea, A ^a   Bechar, M ^a   Pearl, O ^a   Reshef, A ^a   Zamostiano, R ^a   Davidson, A ^a   Rubinraut, S ^b   Giladi, E ^a   Fridkin, M ^b   Brenneman, D E ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; NEUROPEPTIDE; NEUROTROPHIC FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DEATH; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LEARNING DISORDER; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; RAT; SECOND MESSENGER;

ANIMALIA;

EID: 0030912145     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb46154.x     Document Type: Conference Paper

References (33)

1. GOZES, I. & D. E. BRENNEMAN. 1993. Neuropeptides as growth and differentiation factors in general and VIP in particular. J. Mol. Neurosci. 4: 1-9.
2. GOZES, I., D. E. BRENNEMAN, G. LILLING, A. DAVIDSON & T. W. MOODY. 1994. Neuropeptide regulation of mitosis. Ann. N.Y. Acad. Sci. 739: 253-261.
3. PALKOVITS, M. 1995. Neuropeptide messenger plasticity in the CNS neurons following axotomy. Mol. Neurobiol. 10: 91-103.
4. CARNAHAN, J. & H. NAWA. 1995. Regulation of neuropeptide expression in the brain by neurotrophins. Mol. Neurobiol. 10: 135-149.
5. HOKFELT, T., X. ZHANG, & Z. WEISENFELD-HALLIN. 1994. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17: 22-30.
6. SCHWARTZ, J. P. & T. TANIWAKI. 1994. Heterogeneity of expression of neuropeptide genes by astrocytes: Functional implications. Perspect. Dev. Neurobiol. 2: 251-257.
7. MATTSON, M. P. 1994. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta amyloid precursor protein metabolism, free radicals and metabolic compromise. Ann. N.Y. Acad. Sci. 747: 50-76.
8. YAMAMOTO, K., T. MIYOSHI, T. YAE, K. KAWASHIMA, H. ARAKI, K. HANADA, D. A. OTERO, J. M. ROCH & T. SAITOH. 1994. The survival of rat cerebral cortical neurons in the presence of trophic APP peptides. J. Neurobiol. 25: 585-594.
9. ROBINSON, L. J., W. LEITNER, B. DRAZNIN & K. A. HEIDENREICH. 1994. Evidence that p21ras mediates the neurotrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons. Endocrinology 135: 2568-2573.
10. VAUGHAN, P. J., C. J. PIKE, C. W. COTMAN & D. D. CUNNINGHAM. 1995. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15: 5389-5401.
11. FESTOF, B., P. G. NELSON & D. E. BRENNEMAN. 1996. Prevention of activity-dependent neuronal death: Vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting, neurotrophic serpin, protease nexin I. J. Neurobiol. 30: 255-266.
12. SHEN, Y., J. A. HALPERIN & C. M. LEE. 1995. Complement-mediated neurotoxicity is regulated by homologous restriction. Brain Res. 671: 282-292.
13. BRENNEMAN, D. E., M. SCHULTZBERG, T. BARTFAI & I. GOZES. 1992. Cytokine regulation of neuronal survival. J. Neurochem. 58: 454-460.
14. BRENNEMAN, D. E., & L. E. EIDEN. 1986. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA 83: 1159-1162.
15. GOZES, I. & D. E. BRENNEMAN. 1989. VIP molecular biology and neurobiological function. Mol. Neurobiol. 3: 201-236.
16. GRESSENS, P., J. M. HILL, I. GOZES, M. FRIDKIN & D. E. BRENNEMAN. 1993. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 362: 155-158.
17. BALDING, F., JR., S. FITZPATRICK-MCELLIGOTT, I. GOZES & J. P. CARD. 1989. Localization of VIP and PHI-27 messenger RNA in rat thalamic and cortical neurons. J. Mol. Neurosci. 1: 199-207.
18. GLOWA, J. R., L. V. PANLILIO, D. E. BRENNEMAN, I. GOZES, M. FRIDKIN & J. M. HILL. 1992. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res. 570: 49-53.
19. GOZES, I., J. GLOWA, D. E. BRENNEMAN, S. K. MCCUNE, E. LEE & H. WESTPHAL. 1993. Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene. J. Mol. Neurosci. 4: 185-193.
20. BRENNEMAN, D. E., G. L. WESTBROOK, S. P. FITZGERALD, D. L. ENNIST, K. L. ELKINS, M. R. RUFF & C. B. PERT. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642.
21. GOZES, I., A. BARDEA, A. RESHEF, R. ZAMOSTIATNO, S. ZHUKOVSKY, S. RUBINRAUT, M. FRIDKIN & D. E. BRENNEMAN. 1996. Novel neuroprotective strategy for Alzheimer's disease: Inhalation of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA 93: 427-432.
22. YANKNER, B. A., I. K. DUFFY & D. A. KIRSCHNER. 1990. Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides. Science 250: 279-282.
23. PIKE, C. J., D. BURDICK, A. J. WALENCEWICZ, C. G. GLABE & C. W. COTMAN. 1993. Neurodegeneration induced by beta amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13: 1676-1687.
24. GOZES, I., A. RESHEF, D. SALAH, S. RUBINRAUT & M. FRIDKIN. 1994. Stearylnorleucine-VIP, a novel VIP analogue for non-invasive impotence treatment. Endocrinology 134: 2121-2125.
25. GOZES, I., G. LILLING, R. GLAZER, A. TICHER, I. E. ASHKENAZI, A. DAVIDSON, S. RUBINRAUT, M. FRIDKIN & D. E. BRENNEMAN. 1995. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J. Pharmacol. Exp. Ther. 273: 161-167.
26. FISHER, A., R. BRANDEIS, Z. PITTEL, I. KARTON, M. SAPIR, S. DACHIR, A. LEVY & E. HELDMAN. 1989. (+-)-cis-2-methyl-spiro (1.3-oxathiolane-5.3′) quinuclidine (AF102B): A new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats. Neurosci. Lett. 102: 325-331.
27. PITMAN, R. K., S. P. ORR & N. B. LASKO. 1993. Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res. 48: 107-117.
28. CRAWLEY, J. N. 1993. Functional interactions of galanin and acetylcholine: Relevance to memory and Alzheimer's disease. Behav. Brain Res. 57: 133-141.
29. GOZES, I., S. K. MCCUNE, L. JACOBSON, D. WARREN, T. W. MOODY, M. FRIDKIN & D. E. BRENNEMAN. 1991. An antagonist to vasoactive intestinal peptide: Effects on cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257: 959-966.
30. FATATIS, A., L. A. HOLTZCLAW, R. AVIDOR, D. E. BRENNEMAN & J. T. RUSSELL. 1994. Vasoactive intestinal peptide increases intracellular calcium in astroglia: Synergism with alpha-adrenergic receptors. Proc. Natl. Acad. Sci. USA 91: 2036-2040.
31. BRENNEMAN, D. E., E. A. NEALE, G. A. FOSTER, S. W. D'AUTREMONT & G. L. WESTBROOK. 1987. Non-neuronal cells mediate neurotrophic action of VIP. J. Cell Biol. 104: 1603-1610.
32. BRENNEMAN, D. E., T. NICOL, D. WARREN & L. M. BOWERS. 1990. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25: 386-394.
33. BRENNEMAN, D. E. & I. GOZES. 1996. A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97: 2299-2307.